Literature DB >> 9847371

Characterization of the Jembrana disease virus tat gene and the cis- and trans-regulatory elements in its long terminal repeats.

H Chen1, G Wilcox, G Kertayadnya, C Wood.   

Abstract

Jembrana disease virus (JDV) is a newly identified bovine lentivirus that is closely related to the bovine immunodeficiency virus (BIV). JDV contains a tat gene, encoded by two exons, which has potent transactivation activity. Cotransfection of the JDV tat expression plasmid with the JDV promoter chloramphenicol acetyltransferase (CAT) construct pJDV-U3R resulted in a substantial increase in the level of CAT mRNA transcribed from the JDV long terminal repeat (LTR) and a dramatic increase in the CAT protein level. Deletion analysis of the LTR sequences showed that sequences spanning nucleotides -68 to +53, including the TATA box and the predicted first stem-loop structure of the predicted Tat response element (TAR), were required for efficient transactivation. The results, derived from site-directed mutagenesis experiments, suggested that the base pairing in the stem of the first stem-loop structure in the TAR region was important for JDV Tat-mediated transactivation; in contrast, nucleotide substitutions in the loop region of JDV TAR had less effect. For the JDV LTR, upstream sequences, from nucleotide -196 and beyond, as well as the predicted secondary structures in the R region, may have a negative effect on basal JDV promoter activity. Deletion of these regions resulted in a four- to fivefold increase in basal expression. The JDV Tat is also a potent transactivator of other animal and primate lentivirus promoters. It transactivated BIV and human immunodeficiency virus type 1 (HIV-1) LTRs to levels similar to those with their homologous Tat proteins. In contrast, HIV-1 Tat has minimal effects on JDV LTR expression, whereas BIV Tat moderately transactivated the JDV LTR. Our study suggests that JDV may use a mechanism of transactivation similar but not identical to those of other animal and primate lentiviruses.

Entities:  

Mesh:

Year:  1999        PMID: 9847371      PMCID: PMC103872     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Mutational analysis of the equine infectious anemia virus Tat-responsive element.

Authors:  M Carvalho; D Derse
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure.

Authors:  B Berkhout; A Gatignol; J Silver; K T Jeang
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

3.  Characterization of a cDNA clone encoding the visna virus transactivating protein.

Authors:  J L Davis; J E Clements
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target.

Authors:  B Berkhout; R H Silverman; K T Jeang
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

5.  Studies of experimental Jembrana disease in Bali cattle. I. Transmission and persistence of the infectious agent in ruminants and pigs, and resistance of recovered cattle to re-infection.

Authors:  S Soeharsono; N Hartaningsih; M Soetrisno; G Kertayadnya; G E Wilcox
Journal:  J Comp Pathol       Date:  1990-07       Impact factor: 1.311

6.  TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter.

Authors:  B Berkhout; A Gatignol; A B Rabson; K T Jeang
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

7.  Structural and functional characterization of human immunodeficiency virus tat protein.

Authors:  S Ruben; A Perkins; R Purcell; K Joung; R Sia; R Burghoff; W A Haseltine; C A Rosen
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

8.  Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus.

Authors:  K J Garvey; M S Oberste; J E Elser; M J Braun; M A Gonda
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

9.  Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.

Authors:  M Kuppuswamy; T Subramanian; A Srinivasan; G Chinnadurai
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

10.  Replication of an acutely lethal simian immunodeficiency virus activates and induces proliferation of lymphocytes.

Authors:  P N Fultz
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more
  10 in total

1.  Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation.

Authors:  S Wang; S Liu; M H Wu; Y Geng; C Wood
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.

Authors:  H Chen; J He; S Fong; G Wilcox; C Wood
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription.

Authors:  B Berkhout; N L Vastenhouw; B I Klasens; H Huthoff
Journal:  RNA       Date:  2001-08       Impact factor: 4.942

4.  Modulation of human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus replication and transcription activator transactivation by interferon regulatory factor 7.

Authors:  Jinzhong Wang; Jun Zhang; Luwen Zhang; William Harrington; John T West; Charles Wood
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus.

Authors:  M Barboric; R Taube; N Nekrep; K Fujinaga; B M Peterlin
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Bovine immunodeficiency virus: a lentiviral infection.

Authors:  Sandeep Bhatia; S S Patil; R Sood
Journal:  Indian J Virol       Date:  2013-09-27

7.  Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.

Authors:  Baode Xie; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  In Vitro Evaluation of Chitosan-DNA Plasmid Complex Encoding Jembrana Disease Virus Env-TM Protein as a Vaccine Candidate.

Authors:  Januar Ishak; Lalu Unsunnidhal; Ronny Martien; Asmarani Kusumawati
Journal:  J Vet Res       Date:  2019-03-22       Impact factor: 1.744

9.  Comparative functional analysis of Jembrana disease virus Tat protein on lentivirus long terminal repeat promoters: evidence for flexibility at its N-terminus.

Authors:  Yang Su; Gang Deng; Yuanming Gai; Yue Li; Yang Gao; Jiansen Du; Yunqi Geng; Qimin Chen; Wentao Qiao
Journal:  Virol J       Date:  2009-10-28       Impact factor: 4.099

10.  Potential of polylactic-co-glycolic acid (PLGA) for delivery Jembrana disease DNA vaccine Model (pEGFP-C1-tat).

Authors:  Lalu Unsunnidhal; Raden Wasito; Erif Maha Nugraha Setyawan; Ziana Warsani; Asmarani Kusumawati
Journal:  J Vet Sci       Date:  2021-08-30       Impact factor: 1.672

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.